Ambroxol [18683-91-5]
Cat# HY-B1039-100mg
Size : 100mg
Marca : MedChemExpress
| Description |
Ambroxol (NA-872), an active metabolite of the proagent Bromhexine, has potent expectorant effects. Ambroxol is a glucocerebrosidase (GCase) chaperone and increases glucocerebrosidase activity. Ambroxol induces lung autophagy and has the potential for Parkinson disease and neuronopathic Gaucher disease research[1][2]. |
||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| In Vivo |
Ambroxol (NA-872; 1, 3, 4, 5 mM for 12 consecutive days in drinking water) results in increased brain glucocerebrosidase activity in wild-type mice, transgenic mice expressing the heterozygous L444P mutation in the murine glucocerebrosidase 1 gene, and transgenic mice overexpressing human α-synuclein[2]. MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. |
||||||||||||
| Essai clinique |
|
||||||||||||
| Masse moléculaire |
378.10 |
||||||||||||
| Formule |
C13H18Br2N2O |
||||||||||||
| CAS No. | |||||||||||||
| Appearance |
Solid |
||||||||||||
| Color |
White to off-white |
||||||||||||
| SMILES |
O[C@H]1CC[C@H](NCC2=CC(Br)=CC(Br)=C2N)CC1 |
||||||||||||
| Livraison | Room temperature in continental US; may vary elsewhere. |
||||||||||||
| Stockage |
|
||||||||||||
| Solvant et solubilité |
In Vitro:
DMSO : ≥ 200 mg/mL (528.96 mM; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO) *"≥" means soluble, but saturation unknown. Preparing
Stock Solutions
View the Complete Stock Solution Preparation Table
*
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles. Select the appropriate dissolution method based on your experimental animal and administration route.
For the following dissolution methods, please ensure to first prepare a clear stock solution using an In Vitro approach and then sequentially add co-solvents:
|
||||||||||||
| Pureté et documentation | |||||||||||||
| Références |
|

